...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >FORMULATION DEVELOPMENT OF PIOGLITAZONE TABLETS EMPLOYING A NEW CO-PROCESSED EXCIPIENT
【24h】

FORMULATION DEVELOPMENT OF PIOGLITAZONE TABLETS EMPLOYING A NEW CO-PROCESSED EXCIPIENT

机译:使用新的共同加工的辅料制成吡格列酮片剂的配方开发

获取原文

摘要

An efficient platform for the manipulation of excipient functionality is provided by co-processing two or more existing excipients. Co-processing is based on the novel concept of two or more excipients interacting at the sub particle level, the objective of which is to provide a synergy of functionality improvements as well as masking the undesirable properties of individual excipients In the present study a new co-processed excipient consisting of cellulose and ethylcellulose was developed and evaluated for its application in the formulation development of pioglitazone tablets fulfilling the official dissolution rate test specification. Cellulose –EC co-processed excipient was prepared by kneading method and was characterized by determining melting point, solubility, swelling index in water, pH, and micromeritic characters namely particle size, bulk density, tapped density, angle of repose and compressibility index and evaluated for its application as directly compressible vehicle in the formulation of pioglitazone tablets. Cellulose-EC co-processed excipient prepared by kneading method is granular, discrete and free flowing. It is insoluble in water and aqueous fluids of pH 1.2, 4.5 and 7.4. It exhibited slight swelling (24%) in water. Cellulose-EC co-processed excipient has excellent flow properties alone and as blends with the selected drug it exhibited excellent to good flow properties. Pioglitazone tablets prepared by direct compression method employing Cellulose-EC co-processed excipient as DCV were of good quality with regard to drug content, hardness, friability and disintegration time. The tablets formulated disintegrated rapidly within 2 min 40 sec. Pioglitazone tablets prepared gave rapid dissolution of the contained drug and fulfilled the official (IP) dissolution rate test specification prescribed. The formulated tablets also gave rapid and higher dissolution of pioglitazone than the commercial tablets tested. Thus Cellulose-EC co-processed excipient developed in this study was found to be a promising directly compressible vehicle for the preparation of compressed tablets and pioglitazone tablets with rapid disintegration and dissolution characteristics could be developed employing the new co-processed excipient
机译:通过共同处理两种或两种以上现有赋形剂,提供了一种用于操纵赋形剂功能的有效平台。协同处理基于两种或更多种赋形剂在亚颗粒水平上相互作用的新颖概念,其目的是提供功能改进的协同作用,并掩盖单个赋形剂的不良特性。开发了由纤维素和乙基纤维素组成的经加工的赋形剂,并对其在符合正式溶出速率测试规范的吡格列酮片剂的制剂开发中的应用进行了评估。通过捏合方法制备纤维素-EC共处理的赋形剂,并通过测定熔点,溶解度,在水中的溶胀指数,pH和微粒特性(即粒度,堆积密度,堆积密度,休止角和可压缩性指数)进行表征并进行评估在吡格列酮片中作为直接可压缩的载体使用。捏合法制得的纤维素-EC共处理赋形剂为颗粒状,离散,自由流动。它不溶于水和pH 1.2、4.5和7.4的水性液体。在水中略有溶胀(24%)。纤维素-EC共加工的赋形剂单独具有优异的流动性,与所选药物的共混物表现出优异的流动性。采用纤维素-EC共处理的赋形剂作为DCV的直接压片法制备的吡格列酮片剂在药物含量,硬度,脆性和崩解时间方面均具有良好的质量。配制的片剂在2分钟40秒内迅速崩解。制备的吡格列酮片剂可快速溶解所含药物,并符合指定的官方(IP)溶出度测试规范。与所测试的商业片剂相比,配制的片剂还可以使吡格列酮迅速且更高地溶解。因此,本研究中开发的纤维素-EC协同加工赋形剂是制备压制片剂的有前途的可直接压制载体,可以使用新的协同加工赋形剂开发具有快速崩解和溶解特性的吡格列酮片剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号